Medicine and Dentistry
Immunotherapy
100%
Chimeric Antigen Receptor T-Cell
100%
Mesenchymal Stem Cell
100%
Antineoplastic Activity
100%
Tumor Microenvironment
50%
Solid Malignant Neoplasm
33%
Tumor Cell
33%
Interleukin 12
33%
Programmed Death 1 Ligand 1
33%
Neoplasm
16%
Lung Cancer
16%
Tumor Progression
16%
In Vitro
16%
T Cell
16%
Cytokine
16%
Cancer Cell
16%
Virus
16%
Immunosuppressive Drug
16%
Cancer Model
16%
Lung Tumor
16%
Stroma
16%
Cell Therapy
16%
Immunostimulation
16%
Adenoviridae
16%
Cytokine Release
16%
Cytolysis
16%
Tumor Spheroid
16%
Oncolytic Virotherapy
16%
Immunology and Microbiology
Immunotherapy
100%
Mesenchymal Stem Cell
100%
Chimeric Antigen Receptor T-Cell
100%
Antineoplastic Activity
100%
Tumor Cell
33%
Interleukin 12
33%
Programmed Death 1 Ligand 1
33%
Immunosuppressive Drug
16%
Cytokine
16%
T Cell
16%
Cancer Cell
16%
Tumor Spheroid
16%
Virus
16%
Cytokine Release
16%
Adenoviridae
16%
Immunostimulation
16%
Cytolysis
16%
Stroma
16%
Virotherapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Chimeric Antigen Receptor
100%
Antitumor Activity
100%
Neoplasm
83%
Tumor Microenvironment
50%
Solid Malignant Neoplasm
33%
Cytokine
33%
Interleukin 12
33%
Programmed Death 1 Ligand 1
33%
Malignant Neoplasm
16%
Lung Cancer
16%
Tumor Growth
16%
Immunosuppressive Agent
16%
Cancer Model
16%
Adenoviridae
16%
Lung Tumor
16%
Virotherapy
16%
Biochemistry, Genetics and Molecular Biology
Stromal Cell
100%
T Cell
100%
Chimeric Antigen Receptor
100%
Antineoplastic Activity
100%
Interleukin 12
28%
Cytokine
14%
Cancer Cell
14%
Tumor Progression
14%
Cancer Model
14%
Adenoviridae
14%
Cytolysis
14%
Cytokine Release
14%
Tumor Spheroid
14%
Immunostimulation
14%
Keyphrases
Ad Vector
50%
Oncolytic Virotherapy
16%
Binary Vector
16%